When she was switched to semaglutide, a weekly GLP-1 agonist, the symptoms persisted for two additional months
#CreatineForHealth GLP-1 receptor agonists (like semaglutide and tirzepatide) are revolutionizing obesity and type 2 diabetes care, but up to 40% of weight loss may come from lean mass
Its still regulated by state boards of pharmacy and must be prescribed by a licensed provider
If further improvement is needed after another 4 weeks, the dose can be raised to 2 mg weekly
If you expect a rapid disappearance of many pounds in two weeks, you will probably be disappointed
Contact your GP urgently if you experience severe or persistent abdominal pain, repeated vomiting, signs of gastrointestinal bleeding (vomiting blood or black stools), symptoms of dehydration, or unexplained weight loss beyond the expected therapeutic effect